members 24 and the distal legs 22 and 22 a are connected to the distal ends 36 of undulating members 24 in the repetitive cell pattern formed by sinusoidal members 38 and struts 26 the proximal legs 18 18 a and 18 b are connected to the proximal ends 40 of sinusoidal members 38 and the distal legs 22 and 22 a are connected to the distal ends 45 of sinusoidal members 38 it should be understood that the stent device of the present invention may alternatively be coated with an agent such as heparin or rapamycing to prevent stenosis or restenosis of the vessel examples of such coatings are disclosed in u s pat nos 5 288 711 5 516 781 5 563 146 and 5 646 160 the disclosures in these patents are incorporated herein by reference 0035 fig3 illustrates the deployment system 46 for the stent device 10 the deployment system 46 includes an outer sheath 48 which is essentially an elongated tubular member similar to ordinary guiding catheters which are well known to those of ordinary skill in the art the deployment system 46 also includes an inner shaft 50 located coaxially within the outer sheath 48 prior to deployment the inner shaft 50 has a distal end 52 and a proximal end not shown the distal end 52 of the shaft 50 has three grooves 54 54 a and 54 b disposed thereon when the deployment system 46 is not fully deployed the stent device 10 is located within the outer sheath 48 the.